Close Menu

Somalogic

SomaLogic announced that the Massachusetts General Hospital will this fall begin offering access to the company's Somascan assay.
Based on SomaLogic's somamer affinity reagents, the Somascan platform allows for simultaneous quantification of 1,129 proteins.

NEW YORK (GenomeWeb) – Somalogic said this week that it has joined the Medical Research Council's UK Dementias Research Platform.

Protein Metrics has launched top-down proteomic analysis as part of the 2.0 release of its Byonic proteomics search engine.

NEW YORK (GenomeWeb) – Agilent Technologies said this week that it has mad an adjustment to its second quarter 2014 GAAP net income.

NEW YORK (GenomeWeb News) – Somalogic said this week that it has received additional funding from the Bill & Melinda Gates Foundation for the development and validation of tuberculosis biomarker assays based on its Somamer technology.

Somalogic said this week that it has named Dan Muehl as chief financial officer.

While its diagnostic ambitions continue to progress slowly, proteomics firm Somalogic appears to be carving out a substantial market for its SOMAscan protein biomarker discovery platform, generating $10.5 million in revenues from the product in 2013.

SAN FRANCISCO (GenomeWeb News) – The 32nd Annual JP Morgan Healthcare Conference kicked off here Monday with several life science tools and diagnostic firms making presentations to investors and other attendees.

SomaLogic has named Byron Hewett as CEO. Hewett takes replaces Larry Gold, who will continue serving the Boulder, Colo.-based company as chairman of the board. Gold will also work as a full-time adviser, SomaLogic said.

Somalogic this week named Byron Hewett CEO, replacing Larry Gold who will continue as chairman of the board and as a full-time employee at the company.

Pages

The US Food and Drug Administration is to announce stricter standards for emergency authorizations of SARS-CoV-2 vaccines, reports the Washington Post.

The Associated Press reports Johnson & Johnson is starting a late-stage clinical trial of its candidate SARS-CoV-2 vaccine.

Bloomberg reports the budget of Operation Warp Speed is actually $18 billion, higher than the number typically cited.

In Genome Research this week: genomic analysis reveals role of super-spreaders in SARS-CoV-2, epigenetic drivers of cancer, and more.